Anticoagulants (General Class) has 4 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with 6% Hetastarch In 0.9% Sodium Chloride, Latanoprost Ophthalmic Solution 0.005%, Netupitant And Palonosetron. Patients taking Anticoagulants (General Class) should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 4
- Moderate
- 4
Moderate (4)
- Anticoagulants (General Class) + 6% Hetastarch In 0.9% Sodium Chloride— 6% Hetastarch in 0.9% Sodium Chloride should be used with caution in patients anticoagulated with drugs that negatively …
- Anticoagulants (General Class) + Latanoprost Ophthalmic Solution 0.005%— Combined use of two or more prostaglandins or prostaglandin analogs not recommended. Administration more than once daily…
- Anticoagulants (General Class) + Netupitant And Palonosetron— Netupitant inhibits CYP3A4 for 6 days, increasing plasma concentrations of CYP3A4 substrates. Avoid concomitant use for …
- Anticoagulants (General Class) + Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose— Blood concentrations of dialyzable drugs may be reduced by dialysis, requiring dosage adjustment of concomitant medicati…